BioMed Invest ApS: Financial statements 2017
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 136,530 and a net result of DKK -182,822 compared with DKK -771,035 the year before. That is an increase of 76.7% compared with the year before. Equity amounted to DKK 1,597,875. The solvency ratio was 86.2%.
- Gross Profit
- 136,530 kr.
- Profit/Loss
- -182,822 kr.
- Equity
- 1,597,875 kr.
- Total Assets
- 1,854,509 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 137 t. | -183 t. | 1.6 mio. | - |
| 2016 | - | 77 t. | -771 t. | 1.9 mio. | - |
| 2015 | - | - | 218 t. | 2.7 mio. | - |
| 2014 | - | 72 t. | 708 t. | 2.6 mio. | - |
| 2013 | - | 77 t. | 212 t. | 1.9 mio. | - |
Find more companies like BioMed Invest ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
BioMed Invest ApS has published its annual report for 2016. Gross profit came to DKK 77,280, and the net result was DKK -771,035.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.
